Health & Wellness

Gottheimer, FDA Commission meet for a roundtable at Hackensack UMC to discuss pharmaceutical industry problems

(right to left) Congressman Josh Gottheimer (NJ-5), FDA Commissioner Dr. Scott Gottlieb, and Hackensack Meridian Health Co-Chief Executive Officer Dr. Robert Garrett Credits: Courtesy of the Office of Congressman Josh Gottheimer

HACKENSACK, N.J. -- Monday, Congressman Gottheimer (NJ-5) hosted Commissioner of the Food and Drug Administration (FDA) Dr. Scott Gottlieb for a roundtable in Hackensack with local healthcare leaders.

At Hackensack Meridian Health Hackensack University Medical Center, the group discussed cutting red-tape for pharmaceutical and medical device companies, fighting the opioid crisis, and enhancing patient care at New Jersey hospitals.

“New Jersey’s hospitals, biopharmaceuticals, life sciences, and medical device companies are of the utmost importance to our community, state, and even the country; they are among North Jersey’s largest employers.” said Congressman Gottheimer. “I am proud to have the FDA Commissioner here in North Jersey, to listen to our needs and to fight for our doctors, patients, researchers, and companies. New Jersey’s seat at the table will keep jobs here, and to stop them from being sent overseas or to Moocher States.”

Life science companies and hospitals are among North Jersey’s largest employers.The Hackensack Meridian Health system employs 28,000 New Jerseyans.


TAP Into Another Town's News:

Sign Up for E-News


Hackensack University Medical Center is the First in the United States to Earn Joint Commission Certification for its Kidney Cancer Program

May 21, 2018

HACKENSACK, NJ ― Hackensack Meridian Health Hackensack University Medical Center is pleased to announce that it has earned Joint Commission Certification for its Kidney Cancer Program -- the first and only disease-specific certification of its kind in the United States.

“I want to congratulate our team members on a perfect review,” said Ihor S. Sawczuk, M.D., FACS, ...